ENV-501: Clinical Trials

1 trial of ENV-501, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Recruiting 1
Phase 21Recruiting 1

Follow ENV-501: new trials by email Literature Review of ENV-501 trials Research Report on ENV-501

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Phase 1/2 Clinical Trial to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of HMBD-501 in Patients With HER3-Expressing Solid Tumors
ENV-501 - Melanoma (Skin), Non Small Cell Lung Cancer
Phase 1 / Phase 2RecruitingHummingbird Bioscience1802025-12-172026-03-02

Conditions studied

Breast Neoplasms (1)  ·  Carcinoma, Non-Small-Cell Lung (1)  ·  Melanoma (1)

Sponsors

Hummingbird Bioscience (1)

Countries

Australia (1)  ·  United States (1)

Top investigators

Kevin Heller (1)